269 related articles for article (PubMed ID: 17503884)
21. [ACUTE CORONARY SYNDROME AND LIPID-LOWERING THERAPY. DOES THE IMPROVE-IT STUDY MAKE ANY DIFFERENCE?].
Lancellotti P; Pierard LA; Scheen AJ
Rev Med Liege; 2015 Sep; 70(9):450-5. PubMed ID: 26638446
[TBL] [Abstract][Full Text] [Related]
22. Early statin therapy in acute coronary syndromes.
Kinlay S
Minerva Cardioangiol; 2003 Oct; 51(5):577-84. PubMed ID: 14551525
[TBL] [Abstract][Full Text] [Related]
23. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial.
Murphy SA; Cannon CP; Wiviott SD; McCabe CH; Braunwald E
J Am Coll Cardiol; 2009 Dec; 54(25):2358-62. PubMed ID: 20082923
[TBL] [Abstract][Full Text] [Related]
24. Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial.
Eisen A; Cannon CP; Braunwald E; Steen DL; Zhou J; Goodrich EL; Im K; Dalby AJ; Spinar J; Daga S; Lukas MA; O'Donoghue ML
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28077384
[TBL] [Abstract][Full Text] [Related]
25. Meta-analysis of the role of statin therapy in reducing myocardial infarction following elective percutaneous coronary intervention.
Mood GR; Bavry AA; Roukoz H; Bhatt DL
Am J Cardiol; 2007 Sep; 100(6):919-23. PubMed ID: 17826370
[TBL] [Abstract][Full Text] [Related]
26. Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes.
Lenderink T; Boersma E; Gitt AK; Zeymer U; Wallentin L; Van de Werf F; Hasdai D; Behar S; Simoons ML
Eur Heart J; 2006 Aug; 27(15):1799-804. PubMed ID: 16820364
[TBL] [Abstract][Full Text] [Related]
27. [Statin therapy in patients with acute coronary syndrome. "Prove-it" study].
von Schacky C
Internist (Berl); 2004 Dec; 45(12):1437-9. PubMed ID: 15448925
[No Abstract] [Full Text] [Related]
28. High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials.
Wang L; Peng P; Zhang O; Xu X; Yang S; Zhao Y; Zhou Y
PLoS One; 2014; 9(12):e113352. PubMed ID: 25473831
[TBL] [Abstract][Full Text] [Related]
29. Cochrane corner: early statin therapy in acute coronary syndromes--what is the clinical benefit?
Nordmann A; Schwartz G; Vale N; Bucher HC; Briel M
Heart; 2016 May; 102(9):653-4. PubMed ID: 26908101
[No Abstract] [Full Text] [Related]
30. Early statin therapy in patients with acute coronary syndrome.
Liberopoulos EN; Daskalopoulou SS; Mikhailidis DP
Hellenic J Cardiol; 2005; 46(1):5-8. PubMed ID: 15807388
[No Abstract] [Full Text] [Related]
31. Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22).
Ray KK; Morrow DA; Shui A; Rifai N; Cannon CP
Am J Cardiol; 2006 Oct; 98(7):861-5. PubMed ID: 16996863
[TBL] [Abstract][Full Text] [Related]
32. Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry.
Lim MJ; Spencer FA; Gore JM; Dabbous OH; Agnelli G; Kline-Rogers EM; Dibenedetto D; Eagle KA; Mehta RH;
Eur Heart J; 2005 Jun; 26(11):1063-9. PubMed ID: 15716281
[TBL] [Abstract][Full Text] [Related]
33. Updated evidence on early statin therapy for acute coronary syndromes: meta-analysis of 18 randomized trials involving over 14,000 patients.
Briel M; Vale N; Schwartz GG; de Lemos JA; Colivicchi F; den Hartog FR; Ostadal P; Macin SM; Liem A; Mills E; Bhatnagar N; Bucher HC; Nordmann AJ
Int J Cardiol; 2012 Jun; 158(1):93-100. PubMed ID: 21295870
[TBL] [Abstract][Full Text] [Related]
34. Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study.
Spencer FA; Allegrone J; Goldberg RJ; Gore JM; Fox KA; Granger CB; Mehta RH; Brieger D;
Ann Intern Med; 2004 Jun; 140(11):857-66. PubMed ID: 15172899
[TBL] [Abstract][Full Text] [Related]
35. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP;
J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964
[TBL] [Abstract][Full Text] [Related]
36. High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials.
Benjo AM; El-Hayek GE; Messerli F; DiNicolantonio JJ; Hong MK; Aziz EF; Herzog E; Tamis-Holland JE
Catheter Cardiovasc Interv; 2015 Jan; 85(1):53-60. PubMed ID: 24272891
[TBL] [Abstract][Full Text] [Related]
37. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl.
Spencer FA; Goldberg RJ; Gore JM; Fox KA; Avezum A; Agnelli G; Kritharides L; Anderson FA; Goodman SG; FitzGerald G; Allegrone J; Brieger D;
Am J Cardiol; 2007 Sep; 100(6):913-8. PubMed ID: 17826369
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and outcomes of Bempedoic acid versus placebo in patients with statin-intolerance: A pilot systematic review and meta-analysis of randomized controlled trials.
Goyal A; Changez MIK; Tariq MD; Mushtaq F; Shamim U; Sohail AH; Mahalwar G
Curr Probl Cardiol; 2024 Feb; 49(2):102236. PubMed ID: 38043880
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials.
Hoang V; Alam M; Addison D; Macedo F; Virani S; Birnbaum Y
Cardiovasc Drugs Ther; 2016 Apr; 30(2):189-98. PubMed ID: 26861251
[TBL] [Abstract][Full Text] [Related]
40. Lipid-lowering drug use and cardiovascular events after myocardial infarction.
Klungel OH; Heckbert SR; de Boer A; Leufkens HG; Sullivan SD; Fishman PA; Veenstra DL; Psaty BM
Ann Pharmacother; 2002 May; 36(5):751-7. PubMed ID: 11978147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
